Vertical: CNMBase Year: 2025
Market Size (2025)
$165.26M
Projected (2032)
$220.40M
CAGR (2022–2032)
4.7%
Key Players
9+
Market Overview
The Global Aerosol Refrigerants Market was valued at USD 165.26 million in 2025 and is projected to reach USD 220.40 million by 2032, registering a CAGR of 4.12% during the forecast period 2026–2032. The market grew from USD 139.45 million in 2022, and is expected to add USD 55.15 million in value between 2025 and 2032.
Aerosol refrigerants are liquefied fluorinated gases, chiefly hydrofluorocarbons (HFCs) and hydrofluoroolefins (HFOs), that act as propellants in pressurised aerosol containers. They are valued for non-flammability, controlled vapour pressure, low toxicity, chemical stability and, in the United States, exemption from volatile organic compound (VOC) limits. The market is shaped primarily by climate regulation: the Kigali Amendment to the Montreal Protocol, the EU F-gas Regulation and the US AIM Act are steadily restricting high-global-warming-potential (GWP) HFCs such as HFC-134a and accelerating adoption of HFO-1234ze, which has a GWP below 1. This shift raises the average value per kilogram of propellant and is the main reason that market value grows faster than aerosol volumes.
Key Findings
Refrigerant Type: HFC-134a is the largest segment with USD 74.37 million in 2025 (45.0% share), while HFO-1234ze is the fastest-growing at a CAGR of 6.79%, reaching USD 79.79 million by 2032.
Application: Personal Care is the largest segment with USD 66.10 million in 2025 (40.0% share), while Technical Aerosols is the fastest-growing at a CAGR of 5.40%.
Region: North America is the leading region with USD 62.80 million in 2025 (38.0% share). Middle East & Africa is the fastest-growing region at a CAGR of 5.91%, and Asia Pacific adds the largest absolute value, USD 21.94 million, between 2025 and 2032.
Country: The U.S. is the leading country with USD 50.24 million in 2025, equal to 30.4% of the global market. India is the fastest-growing country at a CAGR of 7.89%, rising from USD 6.94 million in 2025 to USD 11.88 million in 2032.
Regulatory mix shift: Europe is the only region in which HFO-1234ze already outsells HFC-134a, with USD 19.01 million in 2025, while HFO-1234ze grows at 13.00% in Asia Pacific and 13.25% in Middle East & Africa.
Segmentation Summary
By refrigerant type, HFC-134a accounted for 45.0% of 2025 value, HFO-1234ze for 30.0% and Others for 25.0%. HFO-1234ze is expected to add USD 30.21 million between 2025 and 2032, more than double the absolute gain of HFC-134a, reflecting regulatory substitution in technical aerosols, dusters and selected personal care products. HFC-134a continues to grow in absolute terms, supported by developing markets and exempt uses, but at the lowest rate among refrigerant types.
By application, Personal Care held 40.0% of 2025 value, Technical Aerosols 35.0% and Others 25.0%. Technical Aerosols are the most dynamic application because non-flammability is frequently a safety requirement and regulation in Europe and the United States is driving reformulation to higher-value HFO-1234ze. Regionally, North America and Europe are mature, regulation-led markets, while Asia Pacific, Latin America and Middle East & Africa combine rising consumption with earlier-stage substitution.
Competitive Landscape Summary
The market is moderately consolidated. The low-GWP segment is concentrated around a small number of technology holders, led by Solstice Advanced Materials (spun off from Honeywell in October 2025), which supplies HFO-1234ze(E) as Solstice Propellant and, in medical grade, as Solstice Air. The Chemours Company, which describes itself as the only US producer of HFC-152a, is a major HFO supplier, Orbia's Fluor & Energy Materials business (Koura) leads the transition of inhalers to HFA-152a, and Arkema supplies Forane HFC-134a and HFC-152a while shifting its portfolio towards HFOs. The HFC-134a segment is more fragmented and price-competitive, with Chinese producers Zhejiang Juhua, Zhejiang Sanmei and Dongyue Group holding most of China's HFC production quota, and SRF Limited operating as India's only HFC-134a producer. Daikin Industries serves the pharmaceutical niche with SOLKANE pharma-grade propellants. Competition centres on low-GWP portfolios, patent positions, pharmaceutical-grade capability, quota holdings and integration into fluorspar and hydrogen fluoride.
Challenges and Opportunities
The principal challenges are regulatory and economic. HFC phase-down schedules progressively reduce the volume of HFC-134a that can be placed on regulated markets, the proposed EU-wide restriction on per- and polyfluoroalkyl substances (PFAS) creates long-term uncertainty for fluorinated propellants, and HFO-1234ze carries a significant price premium over HFC-134a and hydrocarbons, which encourages some formulators to move to flammable hydrocarbons, dimethyl ether, compressed gases or non-aerosol formats. Fluorspar and energy price volatility also affects production costs.
Opportunities centre on the transition to low-GWP propellants. Reformulation of technical aerosols and dusters to HFO-1234ze, the move of metered-dose inhalers to HFC-152a and HFO-1234ze, and the rapid growth of personal care consumption in India, Southeast Asia, Brazil and the Gulf states create new demand pools. Producers that combine secure fluorspar and hydrogen fluoride supply, HFO process technology and pharmaceutical-grade capability are best placed to capture value.
Future Outlook
The market is expected to expand steadily from USD 172.99 million in 2026 to USD 220.40 million in 2032. Growth will be driven more by mix than by volume: as HFC-134a is phased down in regulated markets, higher-priced low-GWP propellants will capture a growing share of value. HFO-1234ze is projected to increase its global share from 30.0% in 2025 to 36.2% in 2032. Asia Pacific will be the largest source of incremental value, while Middle East & Africa and Latin America will grow fastest from smaller bases. Competitive advantage will depend on low-GWP portfolios, regulatory expertise and integrated, cost-competitive production.
The Aerosol Refrigerants Market market is projected to grow at a CAGR of 4.7% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Aerosol refrigerants are liquefied, fluorinated gases with refrigerant-grade or higher purity that are used as propellants in pressurised aerosol dispensers. Stored as a liquid under their own vapour pressure, they provide the energy that expels and atomises the product when the valve is actuated, and in some products, such as freeze sprays and gas dusters, the propellant itself is the active ingredient. The principal chemistries are hydrofluorocarbons such as HFC-134a (1,1,1,2-tetrafluoroethane) and HFC-152a (1,1-difluoroethane), and hydrofluoroolefins such as HFO-1234ze(E) (trans-1,3,3,3-tetrafluoropropene).
For the purposes of this study, the market includes the value of HFC-134a, HFO-1234ze and other fluorinated propellant gases (such as HFC-152a, HFC-227ea and fluorinated propellant blends) sold for use in aerosol products, including pharmaceutical-grade propellants for metered-dose inhalers. Value is measured at the level of propellant sales to aerosol fillers, contract manufacturers, pharmaceutical companies and brand owners.
The study excludes hydrocarbon propellants (propane, butane, isobutane), dimethyl ether, compressed gases (nitrogen, carbon dioxide, nitrous oxide and compressed air), refrigerants sold for stationary or mobile air-conditioning and refrigeration systems, foam-blowing agents, solvents, the value of the finished aerosol products themselves, and aerosol containers, valves and actuators.
Scope of the Study
The study analyses the Global Aerosol Refrigerants Market by refrigerant type, application and region, with country-level analysis within each region. All values are presented in USD Million. Historic data cover 2022 to 2024, 2025 is the base year, and the forecast period covers 2026 to 2032, with compound annual growth rates (CAGR) stated for 2026–2032.
Research Objectives
To estimate and forecast the size of the Global Aerosol Refrigerants Market in value terms (USD Million) for 2022–2032.
To analyse the market by refrigerant type (HFC-134a, HFO-1234ze, Others) and quantify the pace of substitution from high-GWP HFCs to low-GWP HFOs.
To assess demand across Personal Care, Technical Aerosols and Other applications, including medical aerosols and metered-dose inhalers.
To evaluate regional and country-level market sizes and growth rates across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To examine the impact of HFC phase-down regulations, VOC rules and the proposed PFAS restriction on propellant selection and market value.
To identify the drivers, restraints, opportunities, trends and challenges influencing the market through 2032.
To analyse the value chain and competitive intensity using value chain analysis, Porter's Five Forces and PESTEL frameworks.
To profile the competitive landscape, including leading producers, their positioning and key developments since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process designed to produce consistent and verifiable market estimates. The process begins with definition of the market scope and segmentation, followed by extensive secondary research to build a fact base on propellant production, aerosol output, regulation and pricing. Primary research with industry participants is then used to validate assumptions, refine segment splits and test forecasts. Market sizes are estimated using both top-down and bottom-up approaches and reconciled through data triangulation. Forecasts are developed by modelling demand drivers, regulatory schedules and price trends for each segment and region, and the final dataset is reviewed for internal consistency across segments, regions and countries.
Stage 1: Market definition, scope and segmentation framework
Stage 2: Secondary research and fact-base development
Stage 3: Primary research and validation
Stage 4: Market size estimation and triangulation
Stage 5: Forecasting, scenario testing and consistency review
Secondary Research
Secondary research focused on sources specific to fluorochemicals and aerosol packaging, including:
Industry associations: aerosol associations such as the Federation of European Aerosol Associations (FEA), the British Aerosol Manufacturers' Association (BAMA), the Household & Commercial Products Association (HCPA) and national aerosol bodies, together with fluorochemical and refrigerant industry groups, for aerosol production statistics and technical guidance.
Government and regulatory bodies: the US Environmental Protection Agency (SNAP and AIM Act programmes), the European Commission and European Chemicals Agency, the UNEP Ozone Secretariat, and national ozone and environment ministries, for regulatory schedules, HFC quota data and substance listings.
Company filings: annual reports, investor presentations, sustainability reports and press releases of fluorochemical producers, used to understand capacity, product portfolios and strategic priorities.
Trade journals and technical literature: specialist publications on aerosols, packaging, cosmetics and fluorochemicals, along with peer-reviewed literature on propellant properties and atmospheric impact.
Trade and customs data: import and export statistics for fluorinated hydrocarbons, used to understand cross-border flows of propellants.
Paid databases: company, trade and pricing databases used to cross-check revenues, shipments and price trends.
Primary Research
Primary research was conducted through structured and semi-structured interviews with participants across the value chain. On the supply side, respondents included product and business managers at fluorochemical producers, propellant distributors and gas blenders, and technical specialists in propellant formulation. On the demand side, respondents included procurement and research and development personnel at aerosol fillers, contract manufacturers, personal care and household brand owners, technical aerosol producers and pharmaceutical inhaler manufacturers, as well as regulatory and industry association experts.
The objectives of primary research were to validate segment definitions and shares, confirm pricing levels and trends for each propellant type, understand the pace and drivers of reformulation, assess regional differences in demand and regulation, and test the reasonableness of forecast assumptions.
Market Size Estimation
Top-down approach: The overall market was estimated from total fluorinated propellant consumption in aerosols, derived from aerosol production statistics and propellant usage intensities, and then allocated to refrigerant types, applications, regions and countries using shares validated through secondary and primary research.
Bottom-up approach: Country-level consumption of each propellant type was estimated by application using aerosol unit output, average propellant loading per can and average selling prices. Country estimates were aggregated to regional and global totals.
Data triangulation: The results of both approaches were compared with supply-side evidence, including producer capacities, reported revenues and trade flows. Differences were reconciled through further research and expert input, and the final estimates were adjusted so that segment, country and regional values are fully consistent with the global total.
Forecasting Methodology
Forecasts were developed for each segment and country using a combination of driver-based modelling and expert judgement. Factors considered include:
HFC phase-down schedules under the Kigali Amendment, the EU F-gas Regulation, the US AIM Act and national regulations
Product-level GWP limits and VOC regulations affecting aerosol propellant selection
Growth in personal care, household, technical and medical aerosol consumption
Industrial, automotive and electronics production trends
Price trends for HFC-134a, HFO-1234ze and other propellants, including the HFO price premium
Capacity additions and supply availability for low-GWP propellants
Substitution by hydrocarbons, compressed gases and non-aerosol formats
Macroeconomic indicators, including GDP, disposable income and population growth
Base-year values were projected by applying segment-specific growth assumptions to volume and price, with substitution curves used to model the shift between refrigerant types. Forecasts were cross-checked against historic trends and stress-tested against alternative regulatory scenarios.
Assumptions and Limitations
Values are expressed in nominal US dollars; historic values are converted at average annual exchange rates and forecast values assume stable exchange rates.
Regulatory schedules are assumed to be implemented as currently enacted; future changes to HFC phase-down timelines or the adoption of a PFAS restriction could alter the forecast.
Average selling prices are assumed to follow current trends, with a gradual narrowing of the HFO-1234ze price premium as capacity expands.
Market estimates relate to propellant sales and do not capture the value of finished aerosol products.
Country estimates for smaller markets rely more heavily on trade data and modelled consumption, and are therefore subject to higher uncertainty.
Pharmaceutical-grade propellant volumes depend on regulatory approval timelines for low-GWP inhalers, which may differ from current expectations.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global Aerosol Refrigerants Market is moderately consolidated, with a structure that differs sharply by refrigerant type. The HFO-1234ze segment is highly concentrated: production technology is protected by patents, the leading producer has stated that it has not licensed manufacturing rights to other parties, and medical-grade supply requires dedicated, qualified facilities. The HFC-134a segment is more fragmented and commoditised, with large production capacity in China and India and competition driven primarily by price and quota availability. The Others segment, led by HFC-152a, is supplied by a small number of producers in the United States, Europe and Asia.
Competition is shaped by regulation as much as by price. In regulated markets, HFC quota systems allocate production and consumption rights to incumbents, while GWP limits for aerosols shift demand towards low-GWP products in which only a few companies hold technology and capacity. Key competitive factors include low-GWP portfolio breadth, patent positions, pharmaceutical-grade capability and regulatory support, integration into fluorspar and hydrogen fluoride, cost position, supply security and technical service to aerosol fillers and brand owners. Leading producers are investing in HFO and HFC-152a capacity, forming partnerships with pharmaceutical companies, and converting legacy HFC lines to low-GWP products.
Key Player Positioning
Companies are classified qualitatively as leaders, challengers or niche players based on their product portfolios, technology positions, geographic reach and relevance to aerosol propellant markets.
Leaders
Solstice Advanced Materials
Solstice Advanced Materials, headquartered in the United States, became an independent company on 30 October 2025 following its spin-off from Honeywell International. It operates through Refrigerants & Applied Solutions and Electronic & Specialty Materials segments and reported net sales of USD 3,886 million in FY2025. Its aerosol portfolio comprises Solstice Propellant (HFO-1234ze(E)) for consumer and technical aerosols and Solstice Air, a medical-grade HFO-1234ze(E) for metered-dose inhalers, alongside legacy Genetron HFCs. The company holds an extensive patent position on HFO-1234ze manufacturing and has stated that it has invested more than USD 1 billion in HFO technology. Its strategy is to lead the HFC-to-HFO transition in aerosols, inhalers and cooling, build its medical propellant business through pharmaceutical partnerships, and actively defend its intellectual property.
The Chemours Company
The Chemours Company, headquartered in Wilmington, Delaware, reported net sales of USD 5,808 million in FY2025, of which its Thermal & Specialized Solutions segment, home to its refrigerant and propellant products, contributed USD 2,066 million. Its aerosol-relevant products include HFC-152a sold as an aerosol propellant (HP 152a), Freon HFC-134a and the Opteon range of low-GWP HFOs, including Opteon ze (R-1234ze(E)). Chemours states that it is the only US producer of HFC-152a, positioning it as a low-GWP, VOC-exempt propellant. Its strategy is to shift its thermal portfolio towards Opteon low-GWP products, secure domestic supply of HFC-152a, and access additional capacity through partnerships rather than heavy capital spending.
Orbia Advance Corporation (Fluor & Energy Materials / Koura)
Orbia Advance Corporation, headquartered in Mexico City, reported revenue of USD 7,619 million in FY2025, with its Fluor & Energy Materials business, formerly known as Koura, contributing USD 958 million. The business is integrated from fluorspar mining through hydrogen fluoride to refrigerants and medical propellants, marketed under the Zephex brand (Zephex 134a, Zephex 227ea and Zephex 152a) and the Klea refrigerant brand. It opened the world's first HFA-152a medical propellant facility in Runcorn, United Kingdom, in 2022 and is building a commercial-scale HFA-152a plant there. Its strategy is to lead the transition of inhalers to HFA-152a through pharmaceutical partnerships, supported by secure raw material supply.
Arkema
Arkema, headquartered in France, reported sales of EUR 9,068 million in FY2025. It supplies fluorinated gases under the Forane brand, including Forane 134a and Forane 152a for aerosol and other uses, and low-GWP products such as Forane 1233zd and the HFO blend Forane 516A. In 2025 Arkema completed the conversion of its Calvert City, Kentucky, HFC-134a plant into a 15 kt per year Forane 1233zd unit, reducing its US HFC-134a output. Its strategy is to move from commodity HFCs to low-GWP fluorospecialties, treating legacy refrigerants as a business expected to decline towards the end of the decade.
Challengers
Zhejiang Juhua Co., Ltd.
Zhejiang Juhua, headquartered in Quzhou, China, is the largest holder of China's HFC production quotas and reported total operating revenue of RMB 26,991 million in FY2025, with refrigerants accounting for 47.7% of revenue. It produces HFC-134a, R-32, R-125 and blends, as well as HFO-1234yf under licence. In December 2023 it agreed to acquire 51% of Feiyuan Chemical, a producer of R-32, R-125 and R-134a, strengthening its quota position. Its strategy is to consolidate quota through acquisitions, secure fluorspar supply and expand into fluoropolymers and HFOs.
SRF Limited
SRF Limited, headquartered in Gurugram, India, reported revenue of INR 157,870 million in the fiscal year ended March 2026. The company describes itself as India's only producer of HFC-134a and HFC-32, and it owns the Dymel HFA 134a/P pharmaceutical-grade propellant acquired from DuPont in 2015. SRF has expanded its refrigerant capacity at Dahej in stages since 2023 and in May 2026 approved a further increase in HFC capacity beyond 65,000 tonnes per year. Its strategy is to use India's later Kigali timetable to grow HFC production and exports while building specialty fluorochemicals and partnerships with Western producers.
Dongyue Group
Dongyue Group, headquartered in Zibo, Shandong, China, reported revenue of RMB 14,355.4 million in FY2025, with refrigerant external sales rising 52.13% to RMB 4,940.8 million as quota-driven price increases for R-32 and R-134a took effect. Its refrigerant portfolio includes R-134a, R-32, R-125, R-410A and R-22, and it is integrated across fluoropolymers and organosilicon. Its strategy is to maximise the value of its HFC quotas and integrated fluorine value chain.
Zhejiang Sanmei Chemical Industry Co., Ltd.
Zhejiang Sanmei Chemical, headquartered in Wuyi, Zhejiang, China, reported revenue of RMB 5,850 million in FY2025, up 44.81%. It produces hydrofluoric acid, HFC-134a, R-32, R-125 and blends, and holds approximately one quarter of China's R-134a production quota. The company is investing in fluoropolymers and has announced plans for HFO-1234yf. Its strategy is to use its HFC-134a quota position as a cash generator while moving downstream into higher-value fluorine products.
Niche Players
Daikin Industries, Ltd.
Daikin Industries, headquartered in Osaka, Japan, reported revenue of JPY 5,015,000 million in the fiscal year ended March 2026. Alongside its core air-conditioning business, its Chemicals segment supplies fluorochemicals and refrigerants. In the aerosol market Daikin serves the pharmaceutical niche with SOLKANE 134a pharma and SOLKANE 227 pharma propellants for metered-dose inhalers, nasal, foam and topical sprays, produced in Frankfurt, Germany, following its 2015 acquisition of the business from Solvay. Its strategy integrates refrigerant chemistry with its air-conditioning business while investing in high-value fluoromaterials and expansion in Asia.
Competitor Dashboard
The dashboard below rates each profiled company on four dimensions relevant to competitiveness in the aerosol refrigerants market.
Threat of New Entrants: Low
Fluorochemical production is capital-intensive and requires access to hydrogen fluoride and specialised process technology.
HFO-1234ze production and applications are protected by patents held by a small number of producers.
HFC quota systems in regulated markets allocate production and consumption rights to incumbents, limiting new HFC entrants.
Bargaining Power of Suppliers: Medium
Fluorspar supply is geographically concentrated, and prices are sensitive to Chinese export and environmental policies.
Leading producers are backward-integrated into fluorspar and hydrogen fluoride, reducing their exposure.
Non-integrated producers face higher exposure to raw material and energy price volatility.
Bargaining Power of Buyers: Medium
Large personal care and household brand owners purchase in high volumes and can negotiate prices.
Switching propellants requires reformulation, testing and regulatory approval, which limits buyer leverage once products are qualified.
Pharmaceutical buyers require long qualification periods, reducing their ability to switch suppliers quickly.
Threat of Substitutes: High
Hydrocarbons, dimethyl ether and compressed gases are cheaper alternatives in many personal care and household products.
Bag-on-valve and non-aerosol formats such as pumps and roll-ons can replace propellant-based products.
Substitution is limited in applications that require non-flammability, such as dusters, freeze sprays and inhalers.
Competitive Rivalry: High
HFC-134a is a commoditised product with significant capacity in China and India, resulting in intense price competition.
In HFO-1234ze, competition centres on capacity, technical service and regulatory support among a few large producers.
Producers compete through low-GWP portfolio breadth, supply security and pharmaceutical-grade capability.
Threat of New Entrants: Low; High capital requirements, patents and quota-based market access.
Bargaining Power of Suppliers: Medium; Concentrated fluorspar supply offset by producer integration.
Bargaining Power of Buyers: Medium; Large buyers offset by reformulation and qualification costs.
Threat of Substitutes: High; Cheaper hydrocarbons, compressed gases and non-aerosol formats.
Competitive Rivalry: High; Commoditised HFC-134a and concentrated competition in HFOs.
Market estimates by geography (2032)
InsightNorth America leads with $79.90M by 2032, while Asia Pacific is projected to grow fastest at a 6.0% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $54.04M | $67.80M | $79.90M | 4.0% | 36% |
| Europe | $35.70M | $44.48M | $52.01M | 3.8% | 24% |
| Asia Pacific | $39.95M | $55.51M | $71.52M | 6.0% | 32% |
| Latin America | $5.58M | $7.40M | $9.51M | 5.5% | 4% |
| Middle East & Africa | $4.18M | $5.62M | $7.46M | 6.0% | 3% |
| Total | $139.45M | $180.81M | $220.40M | 4.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$220.40M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| HFC-134a | $88.60M | 2.8% | 40% |
| HFO-1234ze | $79.79M | 8.0% | 36% |
| Others | $52.01M | 4.0% | 24% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Aerosol Refrigerants Market covering market dynamics, competitive landscape, and strategic outlook.
The Aerosol Refrigerants Market market is projected to reach $220.40M by 2032, growing at 4.7% CAGR. The HFC-134a segment holds the largest share.
The Global Aerosol Refrigerants Market is shaped by the interaction of climate regulation, end-use demand and the economics of fluorochemical production. Regulations restricting high-GWP HFCs are reducing the volume of legacy propellants but increasing the value of the market as higher-priced, low-GWP alternatives are adopted. At the same time, rising consumption of personal care and technical aerosols in emerging economies is expanding the demand base. This chapter analyses the factors that promote and inhibit growth and assesses their relative influence over the forecast period.
Table 4 summarises five macro and five micro factors. Each factor is classified by impact type as promoting, inhibiting or steady, and is assigned an impact score out of 10 for three forecast windows: 2026–2027, 2028–2030 and 2031–2032. The scores are analyst assessments based on secondary research, regulatory timelines and industry interviews, where a higher score indicates a stronger influence on the market in that period.
HFC Phase-Down Regulations Accelerating the Shift to Low-GWP Propellants
The most important driver of market value is the global phase-down of HFCs. The Kigali Amendment to the Montreal Protocol, in force since 1 January 2019, commits developed and developing countries to staged reductions in HFC production and consumption. In the United States, the American Innovation and Manufacturing (AIM) Act of 2020 mandates an 85% reduction in HFC production and consumption by 2036, and the EPA's Technology Transitions rule restricts the use of higher-GWP HFCs in new aerosol products. In the European Union, the F-gas Regulation has banned high-GWP HFCs in technical aerosols since 2018, and Regulation (EU) 2024/573 sets a path to a complete phase-out of HFC placement on the market by 2050. These measures force brand owners to reformulate products that rely on HFC-134a, and because HFO-1234ze is the most direct non-flammable replacement, each kilogram of substituted propellant is sold at a substantially higher price. The result is that market value grows faster than aerosol volumes, with HFO-1234ze becoming the main source of incremental value.
Expanding Consumption of Personal Care Aerosols
Personal care is the largest application for aerosol refrigerants. Aerosol deodorants, antiperspirants, body sprays, dry shampoos and hair sprays benefit from rising disposable incomes, urbanisation and the growth of modern retail and e-commerce, particularly in India, Southeast Asia, Brazil and the Gulf states. In mature markets, premiumisation, the popularity of dry shampoo and the demand for fine, dry sprays support steady consumption. Fluorinated propellants are used where formulators need reduced flammability, specific spray characteristics or compliance with VOC limits; in the United States, state consumer-product VOC rules encourage the use of VOC-exempt gases such as HFC-152a and HFO-1234ze. Multinational personal care companies are also integrating carbon-footprint targets into product design, which favours low-GWP options in new launches. Together these trends sustain growth in the largest application segment and broaden the geographic base of demand.
Growth of Electronics, Automotive and Industrial Maintenance
Technical aerosols, including gas dusters, freeze sprays, contact cleaners, lubricants and tyre inflators, depend heavily on non-flammable fluorinated propellants because they are used near energised equipment, hot surfaces or ignition sources. Electronics manufacturing and servicing, data-centre maintenance, automotive aftermarket activity and industrial maintenance all generate steady demand. The continued expansion of electronics and automotive production in Asia Pacific, together with growth in the installed base of electronic devices worldwide, supports volume growth. Because technical aerosols face the strictest GWP limits in Europe and the United States, they are also the first to adopt HFO-1234ze, making this application the fastest-growing segment in value terms.
Transition of Metered-Dose Inhalers to Low-GWP Propellants
Pharmaceutical metered-dose inhalers (MDIs) currently use HFA-134a and HFA-227ea, and they represent one of the largest remaining exempt uses of high-GWP HFCs. Pharmaceutical companies have announced programmes to move MDIs to HFC-152a and HFO-1234ze(E), which reduce the carbon footprint of each inhaler by around 90% or more, and propellant producers have invested in pharmaceutical-grade production capacity and regulatory support files. As regulatory reviews progress and HFC phase-down tightens supply of HFA-134a, the transition is expected to create a high-value demand stream for pharmaceutical-grade low-GWP propellants during the forecast period, supporting growth in the Others application segment.
Pharmaceutical-Grade Propellants for Low-Carbon Inhalers
The reformulation of metered-dose inhalers presents the highest-value opportunity in the market. Pharmaceutical-grade propellants require stringent purity, dedicated manufacturing and long-term supply agreements, which support premium pricing and durable customer relationships. Producers that secure qualification with inhaler manufacturers can capture a stable, regulated demand stream as low-GWP inhalers are launched across Europe, North America and other markets.
Low-GWP Adoption in Emerging Markets
Asia Pacific, Latin America and Middle East & Africa are at an early stage of the transition away from HFC-134a, yet they record the highest growth rates for HFO-1234ze. As Kigali Amendment freeze dates approach and multinational brand owners extend global low-GWP standards to regional portfolios, these markets offer significant room for low-GWP propellant growth. Local production, distribution partnerships and technical support for regional aerosol fillers are key to capturing this opportunity.
Capacity Expansion and Localisation of HFO Supply
Supply of HFO-1234ze remains concentrated. New capacity in the United States, Europe, China and India, as well as licensing and partnership models, can reduce cost, improve supply security and narrow the price premium over HFC-134a. Lower prices would in turn widen the range of applications for which HFO-1234ze is economically viable, including mass-market personal care, creating an opportunity for producers that invest early in efficient, integrated capacity.
High Cost of Low-GWP Propellants
HFO-1234ze is produced through multi-step fluorination processes, is covered by process and application patents, and is supplied by a limited number of producers. It is therefore priced at a significant premium to HFC-134a and at a much larger premium to hydrocarbon propellants. For price-sensitive applications, particularly household and mass-market personal care products, this premium encourages formulators to switch to hydrocarbons, dimethyl ether or compressed gases rather than to HFOs, limiting the volume of fluorinated propellants that the market retains as HFCs are phased down.
Substitution by Non-Fluorinated Propellants and Non-Aerosol Formats
Hydrocarbon propellants already dominate personal care and household aerosols in many markets, and compressed gases and bag-on-valve technologies offer propellant-free alternatives for some products. Consumer interest in refillable and non-aerosol formats, such as roll-on deodorants, pump sprays and solid formats, also limits the growth of aerosol packaging. These substitutes cap the addressable market for fluorinated propellants to applications where non-flammability, VOC exemption or specific performance attributes are essential.
Regulatory Uncertainty Around PFAS
Several fluorinated propellants, including HFC-134a and HFO-1234ze, fall within broad definitions of per- and polyfluoroalkyl substances used in some regulatory proposals. The universal PFAS restriction proposal submitted to the European Chemicals Agency in 2023 has raised questions over the long-term availability of fluorinated gases in Europe, and concerns about the atmospheric degradation product trifluoroacetic acid (TFA) have increased scrutiny. This uncertainty can delay investment and reformulation decisions by brand owners.
Challenge: Illegal Trade and Enforcement of HFC Quotas
Quota-based HFC phase-down systems have been accompanied by illegal imports of HFCs in some markets, which undermine compliant suppliers and distort prices. Authorities in the European Union and the United States have strengthened enforcement, including customs monitoring and licensing systems, but illicit supply remains a challenge for legitimate producers.
Challenge: Supply Chain Concentration and Raw Material Security
Production of fluorinated propellants depends on fluorspar and hydrogen fluoride, with significant concentration of fluorspar mining and HFC production in China. Trade tensions, export controls, energy costs and plant outages can disrupt supply, and producers outside China are investing in integrated raw material positions to improve resilience.
Trend: Value Growth Outpacing Volume Growth
As higher-priced HFOs replace HFC-134a, the average value per kilogram of propellant increases. The market's growth is therefore increasingly driven by mix rather than by volume, a trend that is most visible in Europe and North America and is expected to extend to Asia Pacific during the forecast period.
Trend: Carbon-Footprint Labelling and Sustainability Commitments
Brand owners in personal care and household products are setting science-based emissions targets and reporting product carbon footprints. Propellant GWP is a material contributor to the footprint of an aerosol product, encouraging the selection of low-GWP propellants even where regulation does not require it.
The value chain of the Global Aerosol Refrigerants Market extends from fluorspar mining to the end users of aerosol products. Value is concentrated in the manufacturing stage, where proprietary process technology, integration into hydrogen fluoride and regulatory know-how determine competitiveness.
Regulation is the principal determinant of propellant selection in the aerosol industry. The key regulations and standards by major region are summarised below.
Global
Montreal Protocol – Kigali Amendment: Adopted on 15 October 2016 and in force since 1 January 2019, the amendment adds HFCs to the Montreal Protocol and commits parties to cut HFC production and consumption by more than 80% over 30 years. Developed countries began reductions in 2019; most developing (Article 5, Group 1) countries, including China, froze HFC consumption in 2024, while Group 2 countries, including India and the Gulf states, freeze in 2028.
North America
US EPA Significant New Alternatives Policy (SNAP) program: HFC-134a has been listed as unacceptable in aerosol propellant uses since 20 July 2016, except for specified uses, while HFC-152a and HFO-1234ze(E) are listed as acceptable propellant substitutes.
American Innovation and Manufacturing (AIM) Act of 2020: Mandates an 85% phase-down of HFC production and consumption by 2036 through an allowance allocation system administered by the EPA.
EPA Technology Transitions Rule (October 2023): Sets a GWP limit of 150 for consumer aerosol products manufactured or imported from 1 January 2025 and for certain technical aerosols from 1 January 2028, with sale and distribution of non-compliant products prohibited three years after each compliance date. Metered-dose inhalers using HFC-134a or HFC-227ea are excluded.
California Air Resources Board (CARB): Regulates VOC content of consumer products, which favours VOC-exempt propellants, and restricts high-GWP propellants in consumer products such as gas dusters, tyre inflators and boat horns.
Canada – Ozone-depleting Substances and Halocarbon Alternatives Regulations: Implement an HFC consumption phase-down and product-specific restrictions, administered by Environment and Climate Change Canada.
Europe
Regulation (EU) 2024/573 on fluorinated greenhouse gases: In force since 11 March 2024, replacing Regulation (EU) No 517/2014. It phases out the placing of HFCs on the EU market by 2050, brings metered-dose inhalers into the HFC quota system, requires labelling of aerosol dispensers, and prohibits personal care aerosol products containing HFCs from 1 January 2025, except for medical applications, with a further tightening of the technical aerosol restriction scheduled for 2030.
Technical aerosol prohibition: Under the previous F-gas Regulation, technical aerosols containing HFCs with a GWP of 150 or more have been prohibited since 1 January 2018, except where required to meet national safety standards or for medical applications.
REACH and the proposed universal PFAS restriction: A restriction proposal submitted to the European Chemicals Agency (ECHA) in 2023 by Denmark, Germany, the Netherlands, Norway and Sweden covers a broad group of per- and polyfluoroalkyl substances, including several fluorinated propellant gases, and remains under evaluation.
Aerosol Dispensers Directive (75/324/EEC): Sets safety, flammability classification and labelling requirements for aerosol dispensers placed on the EU market.
European Medicines Agency guidance: Sets out data requirements for transitioning oral pressurised metered-dose inhalers to low-GWP propellants.
United Kingdom: Applies its own F-gas regime with aerosol restrictions, while the Medicines and Healthcare products Regulatory Agency (MHRA) approved the first inhaler using HFO-1234ze(E) in May 2025.
Asia Pacific
China: The Kigali Amendment entered into force for China on 15 September 2021, and the Ministry of Ecology and Environment introduced HFC production and consumption quota management from 2024, with annual quota allocations to producers.
India: The Ministry of Environment, Forest and Climate Change regulates ozone-depleting substances under the Ozone Depleting Substances (Regulation and Control) Rules, 2000; India ratified the Kigali Amendment in 2021 and follows the Group 2 schedule, with an HFC freeze in 2028. The India Cooling Action Plan (2019) sets the national framework for refrigerant transition.
Japan: The Act on Rational Use and Proper Management of Fluorocarbons (Act No. 64 of 2001) and the amended Ozone Layer Protection Act implement HFC phase-down and promote low-GWP alternatives.
Australia: The Ozone Protection and Synthetic Greenhouse Gas Management Act 1989 governs the import and use of HFCs, including an HFC import phase-down.
Latin America and Middle East & Africa
Latin America: Mexico and Brazil have ratified the Kigali Amendment and are implementing HFC phase-down programmes through national environmental agencies, with most countries following the Group 1 schedule.
Middle East & Africa: Gulf Cooperation Council states follow the Kigali Amendment Group 2 schedule with an HFC freeze in 2028, while most African countries follow the Group 1 schedule; national ozone units manage import licensing and quotas.
Jul 2022: The Chemours Company; Expansion; Announced a USD 80 million project to increase Opteon YF capacity by about 40% at its Corpus Christi, Texas, site.
Mar 2022: Orbia (Koura); Launch / Expansion; Opened the world's first HFA-152a medical propellant facility in Runcorn, UK, with commercial volumes from mid-2022.
Oct 2022: Honeywell (now Solstice Advanced Materials); Launch / Expansion; Started production of Solstice Air, a medical-grade HFO-1234ze(E) propellant for inhalers, at Baton Rouge, Louisiana.
Aug 2023: Honeywell (now Solstice Advanced Materials); Partnership; Partnered with Recipharm to accelerate development of inhalers using Solstice Air.
Nov 2023: The Chemours Company; Expansion; Announced an approximately 20% increase in HFC-152a capacity at Ingleside, Texas, to support low-GWP, VOC-exempt aerosol propellant demand.
Dec 2023: Orbia (Koura); Partnership; Entered a collaboration with Kindeva Drug Delivery to convert marketed inhalers to Zephex 152a.
Dec 2023: Zhejiang Juhua Co., Ltd.; Acquisition; Agreed to acquire 51% of Feiyuan Chemical, a producer of R-32, R-125 and R-134a, for RMB 1.394 billion.
Dec 2023: SRF Limited; Expansion; Commissioned the first part of a refrigerant gas capacity expansion with raw material integration at Dahej, India.
Dec 2024: Orbia (Koura); Expansion; Advanced construction of a larger commercial-scale Zephex 152a medical propellant plant at Rocksavage, Runcorn, UK.
Feb 2025: SRF Limited; Expansion; Commissioned the remaining part of its Dahej refrigerant gas capacity expansion.
May 2025: Honeywell (now Solstice Advanced Materials); Regulatory Approval; The UK MHRA approved AstraZeneca's Trixeo Aerosphere, the first inhaler using HFO-1234ze(E) propellant supplied by Honeywell.
Aug 2025: Arkema; Expansion / Conversion; Completed conversion of its Calvert City, Kentucky, HFC-134a plant into a 15 kt per year Forane 1233zd unit.
Aug 2025: The Chemours Company / SRF Limited; Partnership; Signed strategic supply agreements giving Chemours access to SRF fluoropolymer and fluoroelastomer capacity.
Oct 2025: Solstice Advanced Materials; Corporate Restructuring; Completed its spin-off from Honeywell International as an independent, publicly listed company.
Mar 2026: Daikin Industries, Ltd.; Expansion; Established Daikin Chemical India Pvt Ltd in Gurugram to sell fluorochemicals and secure refrigerant supply in India.
May 2026: SRF Limited; Expansion; Board approved INR 88 crore to raise HFC production capacity beyond 65,000 tonnes per year.
Aug 2026: The Chemours Company; Launch; Launched Opteon ze (R-1234ze(E)) and Opteon 515B low-GWP refrigerants.
Sep 2026: Solstice Advanced Materials; Intellectual Property; Reaffirmed its patent position on HFO-1234ze manufacturing, stating that it has not licensed production rights to any other party.
Oct 2026: Arkema; Launch; Launched Forane 516A, an HFO-based blend with a GWP below 150 designed to replace R-134a.
Political
International commitments under the Montreal Protocol and Kigali Amendment drive national HFC phase-down policies.
Trade policy, anti-dumping duties on HFC imports and export controls on fluorochemicals affect supply flows and prices.
Industrial policies in China and India support domestic fluorochemical production.
Economic
Rising disposable incomes in emerging markets expand consumption of personal care aerosols.
Fluorspar, hydrogen fluoride and energy price volatility affects production costs and margins.
The price premium of HFOs influences the speed and scope of reformulation.
Social
Consumer awareness of climate impact encourages low-carbon product choices and brand commitments.
Growing use of dry shampoos, body sprays and grooming products supports aerosol demand.
Prevalence of asthma and chronic obstructive pulmonary disease sustains inhaler demand.
Technological
Development of HFO-1234ze and other low-GWP molecules enables non-flammable, low-GWP formulations.
Advances in valve and actuator technology allow lower propellant loading per can.
Process innovation in fluorination and purification lowers HFO production costs.
Environmental
High GWP of HFC-134a drives regulatory restriction and substitution.
Scrutiny of trifluoroacetic acid formation from fluorinated gases influences regulatory debate.
Carbon-footprint reporting by brand owners favours low-GWP propellants.
Legal
EU F-gas Regulation (EU) 2024/573 and the US AIM Act set binding phase-down and product-level restrictions.
VOC regulations for consumer products shape propellant choice in the United States.
Patents covering HFO-1234ze processes and applications create legal barriers to entry.
Profiles of 106 companies operating in the Aerosol Refrigerants Market market, including revenue, employee count, and market positioning where available.
Showing 106 of 106 companies
SRF Limited is a chemicals-anchored Indian multi-business manufacturer that has evolved from a 1970s nylon tyre-cord maker into one of India's most important fluorine-chemistry platforms. Its Chemicals Business — refrigerant gases (HFCs, with HFOs under development), pharma propellants, chloromethanes, fluoropolymers and a contract-manufacturing-led specialty chemicals franchise serving global agrochemical and pharmaceutical innovators — generated 49% of FY2026 revenue and roughly three-quarters of segment EBIT. A second leg, Performance Films & Foil (BOPET, BOPP and aluminium foil, made in India, Thailand, South Africa and Hungary), provides scale and cyclical upside, while Technical Textiles (tyre cord, belting fabrics, industrial yarn) and Coated & Laminated Fabrics are cash-generative legacy franchises. SRF holds 528 patent applications and 159 grants, operates 16 plants, exports to 90+ countries, and is now committing roughly INR 2,300 crore to a greenfield next-generation refrigerant complex in Odisha. The investment case turns on refrigerant regulation, specialty chemicals demand recovery, and execution of a heavy capex cycle. --- ### Company's own description In its Q1 FY2027 press release (22 July 2026), SRF describes itself as "a chemical-based multi-business entity engaged in the manufacturing of industrial and specialty intermediates," with a diversified portfolio covering Fluorochemicals, Specialty Chemicals, Performance Films & Foil, Technical Textiles and Coated and Laminated Fabrics. It cites an annual turnover of INR 15,416 crore (US$1.6 bn, standalone-plus basis used in its boilerplate), a workforce of over 9,500, thirteen manufacturing facilities in India plus one each in Thailand, South Africa and Hungary, and exports to 90+ countries. It emphasises Total Quality Management (TQM) as its "management way" and two Deming Prizes (Tyre Cord and Chemicals businesses). ### Independent characterisation SRF is best understood as a fluorine-chemistry and polymer-processing company with a conglomerate shell. The economic engine is the Chemicals Business, where SRF combines (a) a regulated, quota-sensitive refrigerant franchise — India's leading domestic HFC producer with export reach into the US, Middle East and other markets — and (b) a specialty chemicals arm that performs complex, multi-step fluorination and other chemistries for global agrochemical and pharmaceutical innovators, largely under long-term supply or custom-synthesis arrangements. The Performance Films & Foil Business is a scale commodity-plus business in which margin depends on global BOPET/BOPP supply-demand (notably Chinese capacity) and the share of value-added products (VAPs). Technical Textiles is a mature, oligopolistic Indian business exposed to Chinese import competition.
Company Headquarters: Delaware, US Founded: 2015 Workforce: ~6,400 Company Working: The Chemours Company offers chemicals that are used in the end products and processes in numerous industries. The company also provides specialized solutions with a wide range of industrial and specialty chemicals products to the markets, and include refrigeration, coatings, plastics, air conditioning, transportation, semiconductor, general industrial, consumer electronics, and oil and gas. The product portfolio of the company includes three business segments titanium dioxide pigment, refrigerants, industrial fluoropolymer resins, and performance chemicals and intermediates. The company has three operating business segments that are Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The business segment Titanium Technologies offers TiO2 pigment, a premium white pigment, that is used for whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. The other business segment is Thermal & Specialized Solutions which offers thermal management solutions, refrigerants, propellants, specialty solvents, and blowing agents. The Advanced Performance Materials business segment offers high-end polymers and advanced materials that are used in unique attributes, such as low friction coefficients, weather resistance, ultraviolet and chemical resistance, extreme temperature resistance, and electrical insulation. And the Other Segment includes the Performance Chemicals and Intermediates business and Mining Solutions business. The company has 29 production facilities those are located in nine countries and serves approx. 120 countries consumers.
Dongyue Group is one of China's largest integrated fluorosilicon chemical producers. Its vertically integrated park in Zibo, Shandong runs from anhydrous hydrogen fluoride, chloromethanes and chlor-alkali, through HCFC/HFC refrigerants, to fluoropolymers (PTFE, PVDF, HFP, FEP) and organosilicon monomers and rubbers. The company states that it has the world's largest R22 capacity, and it holds meaningful positions in third-generation HFCs (R32, R125, R134a, R410a blends). Under China's Kigali-driven HFC production quota regime, those positions have turned into a scarce, licence-like asset. That is the core driver of the profit recovery: attributable profit doubled in FY2025 to RMB1.64bn, and H1 2026 rose a further 31.8%. Dongyue's option value sits in perfluorinated membranes (chlor-alkali, fuel-cell and electrolyser PEMs via the associate Future Materials), electronic-grade fluorinated liquids for data-centre liquid cooling, and ultra-high-purity PTFE for high-frequency copper-clad laminates. The investment case is a cyclical commodity chemicals business with an improving regulatory moat, a net-cash balance sheet, and AI-adjacent materials optionality that remains unproven at scale. --- ### Company's own description In its HKEX filings, the Group describes itself as an investment holding company whose subsidiaries manufacture, distribute and sell refrigerants, polymers, organic silicone, dichloromethane, PVC, liquid alkali and other chemical products. Operations are concentrated in the PRC, with export sales. The FY2025 results announcement identifies five operating and reportable segments: (i) Polymers (Fluoropolymers); (ii) Refrigerants; (iii) Organic Silicon; (iv) Dichloromethane and Liquid Alkali; and (v) Other Operations, which covers side-products of the other segments, residual PVC, property development and rental income. (Source: FY2025 annual results announcement, 25 Mar 2026; FY2024 annual results announcement.) ### Independent characterisation Dongyue is a vertically integrated commodity-to-specialty fluorochemical and silicone producer. The economic engine is an integrated chain: **Upstream inputs:** fluorspar-derived anhydrous HF, methanol, chlorine and caustic soda from its own chlor-alkali units, chloromethanes, and silicon metal. A Chinese wiki profile (MoneyDJ) states that about 60% of key refrigerant raw materials are produced in-house. **Midstream:** R22 serves both as a refrigerant (HCFC, quota-controlled and being phased down) and as the essential feedstock for TFE monomer, and therefore for PTFE, HFP and other fluoropolymers. Feedstock use of R22 is exempt from Montreal Protocol consumption limits. This dual role is a structural advantage. The Group's FY2025 report states it has the largest R22 production capacity in the world. **Downstream:** PTFE, PVDF, FEP and HFP fluoropolymers; HFC refrigerants and blends; DMC (organosilicon intermediate), 107 silicone rubber, raw and high-temperature vulcanised rubber; perfluorinated ion-exchange membranes; electronic fluorinated liquids (FC-3283). **Revenue model:** Almost entirely product sales of bulk and semi-specialty chemicals at market-referenced prices. There is no material subscription or licensing revenue. A small amount of property-development and rental income sits in "Other operations". Pricing is cyclical and spot- or contract-referenced. In refrigerants, prices are now strongly influenced by quota-constrained supply. **Value-chain position:** Mid-chain integrated producer. It sells to compounders, appliance OEMs, auto air-conditioning and refrigerant distributors, cable and coatings manufacturers, lithium-battery binder users (PVDF), silicone formulators and construction sealant makers. Historically cited customers include DuPont, Daikin, Mitsubishi, Haier, Hisense, Gree, Midea and Changhong. **End-markets:** Room and commercial air-conditioning; automotive (including NEVs, which carry larger refrigerant charges); cold chain; chemical processing equipment; wire and cable; semiconductors and electronics (high-purity PTFE, fluorinated coolants, HF); lithium-ion batteries (PVDF binder); construction (silicone sealants); hydrogen and flow-battery energy (via Future Materials membranes); and chlor-alkali (ion-exchange membranes). **Customer types:** Industrial B2B. There is no consumer channel.
3 interactive charts drawn from the Aerosol Refrigerants Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Aerosol Refrigerants Market By Application
Global Aerosol Refrigerants Market By Refrigerant Type
Global Aerosol Refrigerants Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
